A U.S. appeals court ruled that the FTC's new rule aimed to ban bait-and-switch tactics does not benefit buyers and is invalid.
Surmodics (NASDAQ:SRDX) dropped 5.8% after a report about the Federal Trade Commission's review of its planned sale to private equity firm GTCR. The staff of the FTC has some concerns about the $627 ...